cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Keros Therapeutics Inc
2 own
3 watching
Current Price
$57.83
$0
(0%)
logo-kros
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,508.04M
52-Week High
52-Week High
68.29
52-Week Low
52-Week Low
24.38
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,508.04M
icon52-Week High68.29
icon52-Week Low24.38
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio--
What does the Keros Therapeutics Inc do?
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company s lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Read More
How much money does Keros Therapeutics Inc make?
News & Events about Keros Therapeutics Inc.
Globe Newswire
1month ago
Keros Therapeutics will be hosting a conference call and webcasttoday, December 12, 2022, at 4:01 p.m. ET.LEXINGTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Keros) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
Globe Newswire
2 months ago
LEXINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Keros) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular ...
Globe Newswire
2 months ago
LEXINGTON, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Keros) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular ...
Globe Newswire
7 months ago
LEXINGTON, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Keros or the Company) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal...
Frequently Asked Questions
Frequently Asked Questions
What is Keros Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Keros Therapeutics Inc shares?
plus_minus_icon
How can I buy Keros Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Keros Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Keros Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Keros Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Keros Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Keros Therapeutics Inc?
plus_minus_icon
What percentage is Keros Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Keros Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$57.83
$0
(0%)
logo-kros
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00